142 results on '"Sieper, Joachim"'
Search Results
2. Review: Nonradiographic axial spondyloarthritis: New definition of an old disease?
3. Are Spondylarthritides Related but Distinct Conditions or a Single Disease With a Heterogeneous Phenotype?
4. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis
5. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis
6. HLA–B27–restricted antigen presentation by human chondrocytes to CD8+ T cells: Potential contribution to local immunopathologic processes in ankylosing spondylitis
7. The Early Disease Stage in Axial Spondylarthritis: Results From the German Spondyloarthritis Inception Cohorta
8. Efficacy and Safety of Golimumab in Patients With Ankylosing Spondylitis: Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
9. Efficacy and Safety of Infliximab in Patients With Ankylosing Spondylitis Over a Two-Year Period
10. Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two
11. Critical appraisal of assessment of structural damage in ankylosing spondylitis: Implications for treatment outcomes
12. Identification of Immunodominant CD4+ T Cell Epitopes in Patients with Yersinia-Induced Reactive Arthritis by Cytometric Cytokine Secretion Assay
13. Immunohistologic Analysis of Zygapophyseal Joints in Patients with Ankylosing Spondylitis
14. Efficacy and Safety of Adalimumab in Patients With Ankylosing Spondylitis: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
15. Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: Evaluation of the bone–cartilage interface and subchondral bone marrow
16. Adalimumab reduces spinal symptoms in active ankylosing spondylitis: Clinical and magnetic resonance imaging results of a fifty-two–week open-label trial
17. Inflammatory Back Pain in Ankylosing Spondylitis: A Reassessment of the Clinical History for Application as Classification and Diagnostic Criteria
18. A cartilage-derived self peptide presented by HLA–B27 molecules? Comment on the article by Atagunduz et al
19. The Challenge of Diagnosis and Classification in Early Ankylosing Spondylitis: Do We Need New Criteria?
20. HLA–B27–Restricted CD8+ T Cell Response to Cartilage-Derived Self peptides in Ankylosing Spondylitis
21. Efficacy and Safety of Infliximab in Patients With Ankylosing Spondylitis: Results of a Randomized, Placebo-Controlled Trial (ASSERT)
22. The implications of biologic therapy in ankylosing spondylitis: comment on the articles by Brandt et al and Braun et al
23. Effect of infliximab treatment on T cell cytokine responses in spondylarthropathy: comment on the article by Zou et al
24. Down-Regulation of the Nonspecific and Antigen-Specific T Cell Cytokine Response in Ankylosing Spondylitis During Treatment With Infliximab
25. Case series of selective anti–tumor necrosis factor [alpha] therapy using infliximab in patients with nonresponsive chronic HLA–B27–associated anterior uveitis: comment on the articles by Brandt et al
26. Refractory inflammatory heel pain in spondylarthropathy: a significant response to infliximab documented by ultrasound
27. Diagnosing Reactive Arthritis: Role of Clinical Setting in the Value of Serologic and Microbiologic Assays
28. Infliximab treatment of severe ankylosing spondylitis: one-year followup
29. PREDICTORS OF IMPAIRMENT, DISABILITY AND HANDICAP IN EARLY RA.
30. HLA-B27+ PATIENTS SUFFERING FROM REACTIVE ARTHRITIS AFTER CHLAMYDIA INFECTION RECOGNIZE HLA-B27 RESTRICTED CHLAMYDIAL PEPTIDES PRESENTED TO THEIR CD8 T-CELLS.
31. IDENTIFICATION OF CHLAMYDIAL IMMUNODOMINANT T-CELL EPITOPE IN PATIENTS WITH THE CHLAMYDIA-INDUCED REACTIVE ARTHRITIS.
32. CHARACTERIZATION OF A YERSINIA (YERS)-HSP60 DERIVED PEPTIDE-SPECIFIC CD4+ T CELL LINE FROM A PATIENT WITH YERSINIA-INDUCED REACTIVE ARTHRITIS (ReA).
33. ANALYSIS OF THE ANTIGEN-SPECIFIC T CELL RESPONSE IN REACTIVE ARTHRITIS BY FLOW CYTOMETRY
34. ASSOCIATION OF GENOTYPES AFFECTING THE EXPRESSION OF INTERLEUKIN-1β OR INTERLEUKIN-1 RECEPTOR ANTAGONIST WITH OSTEOARTHRITIS
35. SUCCESSFUL TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS WITH THE ANTI–TUMOR NECROSIS FACTOR α MONOCLONAL ANTIBODY INFLIXIMAB
36. REPORT ON THE FOURTH INTERNATIONAL WORKSHOP ON REACTIVE ARTHRITIS
37. LOW SECRETION OF TUMOR NECROSIS FACTOR α, BUT NO OTHER Th1 OR Th2 CYTOKINES, BY PERIPHERAL BLOOD MONONUCLEAR CELLS CORRELATES WITH CHRONICITY IN REACTIVE ARTHRITIS
38. NO BENEFIT OF LONG-TERM CIPROFLOXACIN TREATMENT IN PATIENTS WITH REACTIVE ARTHRITIS AND UNDIFFERENTIATED OLIGOARTHRITIS: A Three-Month, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study
39. OVEREXPANDED B CELL CLONE MEDIATING LEUKEMIC ARTHRITIS BY ABUNDANT SECRETION OF INTERLEUKIN-1β: A Case Report
40. LACK OF CORRELATION BETWEEN THE DETECTION OF CHLAMYDIA TRACHOMATIS DNA IN SYNOVIAL FLUID FROM PATIENTS WITH A RANGE OF RHEUMATIC DISEASES AND THE PRESENCE OF AN ANTICHLAMYDIAL IMMUNE RESPONSE
41. CHARACTERIZATION OF THE SYNOVIAL T CELL RESPONSE TO VARIOUS RECOMBINANTYERSINIA ANTIGENS IN YERSINIA ENTEROCOLITICA-TRIGGERED REACTIVE ARTHRITIS: Heat-Shock Protein 60 Drives a Major Immune Response
42. ORAL COLLAGEN IN THE TREATMENT OF RHEUMATOID ARTHRITIS
43. PREVALENCE OF SPONDYLARTHROPATHIES IN HLA-B27 POSITIVE AND NEGATIVE BLOOD DONORS
44. CRUCIAL ROLE OF INTERLEUKIN-10/INTERLEUKIN-12 BALANCE IN THE REGULATION OF THE TYPE 2 T HELPER CYTOKINE RESPONSE IN REACTIVE ARTHRITIS
45. Recognition of Chlamydial Antigen by HLA-B27-restricted Cytotoxic T Cells in HLA-B sup * 2705 Transgenic CBA (H-2 sup k) Mice
46. T Cell Cytokine Pattern in the Joints of Patients with Lyme Arthritis and Its Regulation by cytokines and Anticytokines
47. Oral Type II Collagen Treatment in Early Rheumatoid Arthritis: A Double-Blind, Placebo-Controlled, Randomized Trial
48. Review: Pathogenesis of Spondylarthropathies: Persistent Bacterial Antigen, Autoimmunity, or Both?
49. Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?
50. Identification of immunodominant CD4+ T cell epitopes in patients withYersinia-induced reactive arthritis by cytometric cytokine secretion assay
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.